1. Cheng, Meng, Yang, Qingmiao, Liu, Yafei, Xu, Ximing, Du, Hai-Ning. 2022. SETD3 Methyltransferase Regulates PLK1 Expression to Promote In Situ Hepatic Carcinogenesis. In Frontiers in oncology, 12, 882202. doi:10.3389/fonc.2022.882202. https://pubmed.ncbi.nlm.nih.gov/35912180/
2. Zou, Tingting, Wang, Yang, Dong, Ling, Yan, Xiaohua, Lin, Zhenghong. 2022. Stabilization of SETD3 by deubiquitinase USP27 enhances cell proliferation and hepatocellular carcinoma progression. In Cellular and molecular life sciences : CMLS, 79, 70. doi:10.1007/s00018-021-04118-9. https://pubmed.ncbi.nlm.nih.gov/35018513/
3. Abaev-Schneiderman, Elina, Admoni-Elisha, Lee, Levy, Dan. 2019. SETD3 is a positive regulator of DNA-damage-induced apoptosis. In Cell death & disease, 10, 74. doi:10.1038/s41419-019-1328-4. https://pubmed.ncbi.nlm.nih.gov/30683849/
4. Cohn, Ofir, Feldman, Michal, Weil, Lital, Kublanovsky, Margarita, Levy, Dan. 2016. Chromatin associated SETD3 negatively regulates VEGF expression. In Scientific reports, 6, 37115. doi:10.1038/srep37115. https://pubmed.ncbi.nlm.nih.gov/27845446/
5. Zhao, Meng-Jie, Xie, Jun, Shu, Wen-Jie, Jiang, Wei, Du, Hai-Ning. 2019. MiR-15b and miR-322 inhibit SETD3 expression to repress muscle cell differentiation. In Cell death & disease, 10, 183. doi:10.1038/s41419-019-1432-5. https://pubmed.ncbi.nlm.nih.gov/30796205/
6. Kong, Yue-Yu, Shu, Wen-Jie, Wang, Shuang, Li, Ke, Du, Hai-Ning. 2024. The methyltransferase SETD3 regulates mRNA alternative splicing through interacting with hnRNPK. In Cell insight, 3, 100198. doi:10.1016/j.cellin.2024.100198. https://pubmed.ncbi.nlm.nih.gov/39391005/
智鼠故事 
